StockNews.com Begins Coverage on Sorrento Therapeutics (NASDAQ:SRNE)
Stock analysts at StockNews.com initiated coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Get Free Report) in a report released on Thursday. The firm set a “hold” rating on the ...
生物通8 小时
BCMA 靶向疗法治疗多发性骨髓瘤的新进展：2024 ASH 年会成果解读
综上所述，2024 ASH 年会展示的这些 BCMA 靶向疗法的临床试验结果令人振奋，为 MM 患者带来了新的希望。这些研究成果不仅进一步证实了 BCMA 靶向疗法在 MM 治疗中的有效性，还为不同阶段 MM ...